Table 2. Medications at Discharge.
| Medication | No. (%) | |
|---|---|---|
| NP202 (n = 66) | Placebo (n = 71) | |
| ACE inhibitors/ARBs | 65 (99) | 63 (89) |
| β-Blockers | 63 (96) | 69 (97) |
| MRAs | 12 (18) | 23 (32) |
| Statins | 65 (99) | 68 (96) |
| SGLT2 inhibitors | 0 | 3 (4) |
| Aspirin | 66 (100) | 69 (97) |
| Clopidogrel | 26 (39) | 24 (34) |
| Prasugrel | 4 (6) | 5 (7) |
| Ticagrelor | 42 (64) | 47 (66) |
| OAC | 11 (17) | 8 (11) |
| Metformin | 11 (17) | 8 (11) |
| Insulin | 9 (14) | 11 (15) |
Abbreviations: ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; MRA, mineralocorticoid receptor antagonist; OAC, oral anticoagulant; SGLT2, sodium-glucose cotransporter 2.